ALFA Finder| Revenue growth | H1 total income +19% to ₹4,717 Cr; Care GWP +35%. |
|---|---|
| Margins | Care H1 combined ratio 100.5% (Ind AS), improved 70 bps. |
| Demand visibility | Broking Q2 market subdued; Care retail momentum; distribution rules uncertain. |
| Management confidence | Optimistic; repeatedly hedged ('hope', 'speculation') on key items. |
Growth
Care GWP +35% to ₹6,897 Cr; H1 income +19% to ₹4,717 Cr; RFL Q2 profit lifted by GNPA recoveries, not new lending.
Outlook
RFL disbursements ₹1,500–1,700 Cr FY28; combined ratio near 100% by March 2028; ₹300 Cr rights issue planned.
Risks
Consolidated loss persists; solvency 1.55x needs ₹800 Cr warrant inflows by March 2027; D-merger has no timeline.
Last quarter's promises, checked
Delivered
- Care sub-debt ₹200 Cr (Aug-26) → ₹450 Cr raised (= BEAT)
Partly delivered
- Care combined ratio 100% within 2 yrs → H1 100.5% Ind AS (= PARTIAL)
- RFL business start in 3–4 months → first loan, 3 branches; no volumes disclosed (= PARTIAL)
- Warrant conversion ₹881 Cr due by Mar-27 → ₹800 Cr still needed by Mar-27 (= PARTIAL)
Missed
- Care solvency 1.7x target → 1.55x (= MISS)
- Q1 FY28 demerger (analyst-cited; mgmt agreed delay likely) → no timeline (= MISS)
Earnings Call Transcript filed with NSE, NSE: RELIGARE. Summary written with AI assistance from the document.
Religare Enterprises Ltd: key numbers
- Share price
- ₹233.93
- Market cap
- ₹8,065 Cr
- Revenue (annual)
- ₹8,459 Cr
- Net profit (annual)
- ₹85.96 Cr
- P/E (TTM)
- -238.1×Sector 21.0×
- Promoter holding
- 31.26%+0.70% QoQ
- FII holding
- 9.76%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Religare Enterprises Ltd
All →Religare Enterprises Other Announcement
Religare Enterprises filed CARE Ratings' monitoring agency report for the quarter ended September 30, 2026, on its Rs 1,500 crore preferential warrant issue. The report states proceeds were used per the offer document with no deviation.
Religare Enterprises Investor Presentation: Key Takeaways
Religare H1 FY27 consolidated total income Rs4,717 Cr (+19% YoY); PAT loss Rs145 Cr vs Rs54 Cr profit last year. Care GWP growth drives insurance; Finvest lending restarted 6 Nov 2026.
Religare Enterprises Q2 FY27 Results: Net Loss of ₹97.7 Cr
Religare Enterprises Ltd reported revenue from operations of ₹2,381 Cr (+14.6% YoY) and a net loss of ₹97.7 Cr for Q2 FY27.
- Key figure
- Net loss ₹97.7 Cr
Religare Enterprises Employee Stock Options
Religare Enterprises' NRC granted 25,998 stock options under its ESOP 2019 scheme. Options vest in 5 equal annual tranches at Rs. 230.78 per share exercise price.
Religare Enterprises Business Update
Religare Finvest, a material subsidiary, resumed lending after RBI lifted its Corrective Action Plan. It disbursed its first Loan Against Property on 6 November 2026.
Religare Enterprises Board Meeting Date
Religare Enterprises intimated a board meeting on November 12, 2026 to consider unaudited standalone and consolidated results for the quarter ended September 30, 2026. The trading window stays closed until November 14, 2026.